The success of HLA genotypically identical bone marrow grafting is still hampered by graft vs host disease and rejection of the graft. One of the causes of the latter complication could be attributed to minor histocompatibility (mill) antigen disparities between HLA genotypically identical siblings (Goulmy 1988 ). In previous in vitro studies, we demonstrated the presence of anti-host cytotoxic T cell (CTL) as well as proliferative (Th) T cell reactions in blood-samples taken after HLA identical bone marrow transplantation (van Els 1990a, b) . The latter activities are directed against mill antigens which are recognized in association with MHC class I (CTL) and class II (Th) products (Goulmy 1988; van Els 1990c) . We recently acquired CTL clones specific for five non-sexlinked mill antigens designated HA-l, -2, -3, -4, and -5, whereby HA-l, -2, -4, and -5 use the HLA-A2 gene product as,restriction molecule. Using the latter CTL clones, immunogenetic studies were carried out to determine the mill antigen gene frequencies and to study the mill antigen segregation patterns in families. One complication in these studies is that it is necessary for the HLA-A2 molecule to be present in order to detect the mill antigens. As illustrated in Figure la , the HLA-A2 positive identical siblings 02 and 03 carry mill antigens HA-1 and -2. Since the father (01) of family B only posseses HA-2, the mill antigen HA-1 must have been inherited from the mother. Therefore, the absence of the required MHC class I HLA-A2 restricting antigen hampers adequate genetic analysis in this and other families.
In order to solve this deficit, we used electroporation (Potter et al. 1984) to introduce cloned HLA genes into the Epstein-Barr transformed B cell lines of selected members of this family. We transfected the HLA-A2 gene cloned in the pHEBO vector (Sugden et al. 1985; Shimizu et al. 1986 ) into the HLA-A2 negative cells of the mother (00) and into three HLA identical, HLA-A2 negative family members 04, 05, and 06 ( Fig. la) . Fluorescence activated cell sorter (FACS) analyses using the class I and HLA-A2 specific monoclonal antibodies were carried out and demonstrated the surface expression of the HLA-A2 gene product on all transfected cells (Fig. 2) . Subsequently, the transfected cell lines were subjected to mill typing. Figure lb shows that we were indeed able to trace the mill antigen HA-l, which after HLA-A2 gene transfection appeared to be inherited from the mother (00). Furthermore, the cells from three children (04, 05, 06) who did not carry the A2 allele and thus could not be tested for the presence of mill antigen HA-I and -2, were now amenable to the CTL analysis. In addition to using the mill HA-1 and HA-2 specific CTL clones, we also tested HLA-A2 allospecific and HLA-A2 restricted H-Y specific CTL clones on the cells of all family members. As shown in Figure  lb , A2 allo-specific, A2 restricted mill antigen H-Y, HA-1, and HA-2-specific CTLs lysed the transfected cells to the same extent as the naturally expressing HLA-A2 cells. To confirm that we were actually dealing with identical MHC/miH antigen peptide complexes, cold target inhibition studies were carried out. Table 1 shows that HLA-A2 transfectants were equally potent as cold target inhibitors of HLA-A2 directed lysis as their naturally expressing HLA-A2 counterparts. Non-transfected target cells failed to show any inhibition.
In conclusion, we have used gene transfection to circumvent the lack of the required MHC restriction molecule for mill antigens HA-l, -2, and H-Y recognition. Similar to the naturally expressed A2 gene products, the transfected gene products associate with the mill peptide(s) creating an assemblage suitable for A2/miH antigen specific T-cell receptor recognition. Recognition of human mill antigens upon implantation or by gene transfection of the required HLA antigens has been reported previously (Zier et al. 1987 , Yamamoto et al. 1990 ). Our results are in line with both latter reports. The data shown here clearly demonstrate that gene transfection yields cell E1 Goulmy et Antibody 9E8 Antibody P20.1 E 0 4 + A 2 ~ Log F/uorescence Zntensity Fig. 2 . The EBV-LCLs of family members 00, 04, 05, and 06 were transfected by electroporation (Potter et al. 1984 ) using the HLA-A2 gene cloned in the pHEBO vector (Shimizu et al. 1986 ). Selected cell growth was made possible by the presence of hygromycine B. The cells were stained by a standard indirect fluorescence technique using the indicated monoclonal antibodies and FITC labeled goat anti-mouse and analyzed on a FACS analyzer. % Specific lysis at two effector/target ratio, i.e., 20: i and 2:1. * Note that 01 is HA-1 negative but HA-2 positive. The generation of mill antigen specific CTLs has been described in detail (Goulmy 1988) . Specific cytotoxic T cell activity was measured by the cell-mediated-lympholysis assay previously described (Goulmy 1982) . The hot:cold target cell ratio used is 1:10.
surface expressed MHC products resulting not only in high levels of specific lysis by both allo-and MHC restricted mill antigen specific CTLs, but also in comparable inhibiting capacities. Consequently, gene transfection has proved to be a reliable technique for adequate mill antigen recognition and thus broadens its immunogenetic analyses.
